Over the last few weeks, several events have suggested that the US is ready to move beyond the Covid-19 pandemic. Future waves of increased transmission are, however, still possible. Under this threat, it is still prudent to deploy public health measures to prevent or mitigate future outbreaks. These actions may require another round of vaccinations in the near future, even among individuals who have already received their booster shots. 

Last month, US Chief Medical Officer Dr Anthony Fauci announced an ‘end to the pandemic phase’ of Covid-19, and a federal judge struck down the Centres for Disease Control and Prevention’s (CDC) mask mandate for the time being. This may lead to confidence that the pandemic is over and result in lower adherence to public health measures designed to reduce Covid-19 transmission, such as further vaccinations. Despite this, the timeline for the end of the Covid-19 epidemic remains unclear, and while Fauci clarified his statement and the US Department of Justice (DOJ) is appealing the federal judge’s ruling, further public health action may be necessary. After all, Covid-19 transmission over the past two years has tended to be lower in warmer months before increasing later in the year, and waning immunity in the population may also exacerbate the possibility of another wave of transmission.

Preliminary data from a multicentre cohort study of 2,602 patients hospitalised with severe Covid-19 across 14 medical centres in Israel during the Omicron wave suggest that patients hospitalised with severe Covid-19 who were given a recent fourth dose had 49% lower odds for a poor outcome when compared with those who received three doses around five months before diagnosis. While the study design made it difficult to determine if the additional booster dose reduces the severity of Covid-19, it does suggest that a fourth dose may improve clinical outcomes and subsequently have the potential to reduce the number of hospitalisations and deaths. As such, an additional round of booster vaccinations may be an appropriate response to uphold the current trends that have sparked assertions of an end to the pandemic phase of Covid-19.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Without taking such action, another sharp rise in cases could be more severe in terms of hospitalisations and deaths, as shown in Figures 1 and 2. Figure 2 shows more than 994,000 hospitalisations in the US alone, according to GlobalData. Therefore, because vaccines take time to build immunity and immunity may wane over time, individuals should also ensure that they are up to date on their Covid-19 vaccines.

See Also: